IP Verse

Coalition for Affordable Drugs III LLC vs Jazz Pharmaceuticals, Inc.

The detailed information for PTAB case with proceeding number IPR2015-01018 filed by Coalition for Affordable Drugs III LLC against Jazz Pharmaceuticals, Inc. on Apr 6, 2015. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: IPR2015-01018
Filing Date: Apr 6, 2015
Petitioner: Coalition for Affordable Drugs III LLC
Respondent: Jazz Pharmaceuticals, Inc.
Status: Institution Denied
Respondent Application Number: 12704097
Respondent Tech Center: 3600
Respondent Patent Number: 7895059
Institution Decision Date: Oct 15, 2015
Termination Date: Oct 15, 2015

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
Decision - Denying Institution of Inter Partes Review - 37 C.F.R. 42.108	Oct 15, 2015	PAPER	BOARD
Patent Owner Response to the Board's Request for Additional Briefing	Sep 28, 2015	PAPER	PATENT OWNER
Patent Owner Exhibit List	Sep 28, 2015	PAPER	PATENT OWNER
Center for Economic and Policy Research - The Naked Truth on Short-Selling	Sep 28, 2015	EXHIBIT	PATENT OWNER
Petitioner's Brief in Response to the Board's Request for Additional Briefing	Sep 21, 2015	PAPER	PETITIONER
Petitioner's Updated Exhibit List	Sep 21, 2015	PAPER	PETITIONER
Joint letter from AARP, AHIP, BCBSA and PCMA to Chairmen Grassley and Goodlatte and Ranking Members Leahy and Conyers	Sep 21, 2015	EXHIBIT	PETITIONER
Center for Economic and Policy Research paper titled The Impact of Exempting the Pharmaceutical Industry from Patent Reviews by Dean Baker	Sep 21, 2015	EXHIBIT	PETITIONER
Patent Owner Preliminary Response	Jul 16, 2015	PAPER	PATENT OWNER
Patent Owner Exhibit List	Jul 16, 2015	PAPER	PATENT OWNER
PR Newswire - FDA Issues GHB Warning	Jul 16, 2015	EXHIBIT	PATENT OWNER
U.S. FDA - Import Alert 66-60 Detention Without Physical Examination of Certain Steroid Alternatives	Jul 16, 2015	EXHIBIT	PATENT OWNER
Centers for Disease Control - Gamma Hydroxy Butyrate Use - New York and Texas	Jul 16, 2015	EXHIBIT	PATENT OWNER
National Institute on Drug Abuse - NIDA Community Drug Alert Bulletin - Club Drugs	Jul 16, 2015	EXHIBIT	PATENT OWNER
Office of National Drug Control Policy - Gamma Hydroxybutyrate (GHB)	Jul 16, 2015	EXHIBIT	PATENT OWNER
Date Rape Drugs - Hearing Before the Subcomm. on Oversight and Investigations of the H. Comm. on Commerce 106th Cong.	Jul 16, 2015	EXHIBIT	PATENT OWNER
Substance Abuse and Mental Health Services Administration - Advisory - GHB A Club Drug to Watch	Jul 16, 2015	EXHIBIT	PATENT OWNER
National Drug Intelligence Center - Information Bulletin GHB Analogs GBL BD GHV and GVL	Jul 16, 2015	EXHIBIT	PATENT OWNER
Controlled and Uncontrolled Substances Used to Commit Date Rape - Hearing Before the Subcomm. on Crime of the H. Comm. on the Judiciary, 105th Cong.	Jul 16, 2015	EXHIBIT	PATENT OWNER
Date Rape Drugs - Hearing Before the Subcomm. on Oversight and Investigations of the H. Comm. on Commerce, 106th Cong.	Jul 16, 2015	EXHIBIT	PATENT OWNER
Hillory J. Farias and Samantha Reid Date-Rape Drug Prohibition Act of 2000	Jul 16, 2015	EXHIBIT	PATENT OWNER
146 Cong. Rec. H55-62	Jul 16, 2015	EXHIBIT	PATENT OWNER
Letter from Dr. Robert Temple Director ODE I to Dr. Dayton T. Reardan Orphan Medical Inc.	Jul 16, 2015	EXHIBIT	PATENT OWNER
Letter from Dr. Russell Katz Director Division of Neurology Products ODE I to Dr. Dayton T. Reardan Orphan Medical Inc.	Jul 16, 2015	EXHIBIT	PATENT OWNER
059 Patent Notice of Allowance	Jul 16, 2015	EXHIBIT	PATENT OWNER
Delaware Department of State - Division of Corporations - Coalition for Affordable Drugs	Jul 16, 2015	EXHIBIT	PATENT OWNER
Delaware Department of State Division of Corporations - Coalition for Affordable Drugs III LLC - Entity Details	Jul 16, 2015	EXHIBIT	PATENT OWNER
The Wall Street Journal - New Hedge Fund Strategy Dispute the Patent Short the Stock	Jul 16, 2015	EXHIBIT	PATENT OWNER
Business Insider - Hedge Fund Manager Kyle Bass Is Going After Big Pharma And Its BS Patents	Jul 16, 2015	EXHIBIT	PATENT OWNER
The Wall Street Journal - Innovate or Else Kyle Bass Strikes Again and Challenges Shire Patents	Jul 16, 2015	EXHIBIT	PATENT OWNER
Law360 - Shire Drugs Are Next Targets of Hedge Fund AIA Reviews	Jul 16, 2015	EXHIBIT	PATENT OWNER
Hayman Capital Management L.P. Form ADV Part 2A Brochure	Jul 16, 2015	EXHIBIT	PATENT OWNER
Wayback Machine Archive of the URL corresponding to Ex. 1005	Jul 16, 2015	EXHIBIT	PATENT OWNER
Petitioner's Motion for Admission Pro Hac Vice of Brent E. Routman	Jul 15, 2015	PAPER	PETITIONER
Petitioner's Updated Exhibit List	Jul 15, 2015	PAPER	PETITIONER
Certificate of Service	Jul 15, 2015	PAPER	PETITIONER
Declaration of Brent E. Routman in Support of Petitioner's Motion for Admission Pro Hac Vice	Jul 15, 2015	EXHIBIT	PETITIONER
Power of Attorney	Apr 27, 2015	PAPER	INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER.
Power of Attorney	Apr 27, 2015	PAPER	INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER.
Related Matters	Apr 27, 2015	PAPER	INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER.
Notice of Filing Date Accorded to Petition	Apr 16, 2015	PAPER	BOARD
Petition for Inter Partes Review of U.S. Patent No. 7,895,059	Apr 6, 2015	PAPER	PETITIONER
Petitioner's Exhibit List	Apr 6, 2015	PAPER	PETITIONER
Power of Attorney	Apr 6, 2015	PAPER	PETITIONER
U.S. Patent No. 7,895,059	Apr 6, 2015	EXHIBIT	PETITIONER
Patent Application Publication No. US 2004/0176985	Apr 6, 2015	EXHIBIT	PETITIONER
Transcript of Department of Health and Human Services Food and Drug Administration Center	Apr 6, 2015	EXHIBIT	PETITIONER
U.S. Patent No. 6,587,829	Apr 6, 2015	EXHIBIT	PETITIONER
Division of Neuropharmacological Drug Products Preliminary Clinical Safety Review of NDA for Xyrem	Apr 6, 2015	EXHIBIT	PETITIONER
Declaration by Dr. Jeffrey Fudin, Regarding U.S. Patent No. 7,895,059	Apr 6, 2015	EXHIBIT	PETITIONER
Curriculum Vitae of Jeffrey Fudin, R.Ph., B.S., Pharm.D., DAAPM, FCCP	Apr 6, 2015	EXHIBIT	PETITIONER
Reply Brief Under 37 CFR 41.41	Apr 6, 2015	EXHIBIT	PETITIONER
Websters Third New International Dictionary	Apr 6, 2015	EXHIBIT	PETITIONER
Sodium oxybate article from Wikipedia.org	Apr 6, 2015	EXHIBIT	PETITIONER
LinkedIn Profile for Dayton Reardan	Apr 6, 2015	EXHIBIT	PETITIONER
LinkedIn Profile for Patti Engel	Apr 6, 2015	EXHIBIT	PETITIONER
Power of Attorney Change of Correspondence Address	Apr 6, 2015	EXHIBIT	PETITIONER
PAIR Patent Assignment Abstract of Title	Apr 6, 2015	EXHIBIT	PETITIONER
Federal Register Vol. 66, No. 93	Apr 6, 2015	EXHIBIT	PETITIONER
U.S. Food and Drug Administration 2001 Meeting Documents	Apr 6, 2015	EXHIBIT	PETITIONER
CDER 2001 Meeting Documents	Apr 6, 2015	EXHIBIT	PETITIONER